• News
  • SAN DIEGO
  • Health

Sorrento Therapeutics adds Amar Singh as executive VP

Sorrento Therapeutics Inc. (Nasdaq: SRNE) has appointed Amar Singh to be its executive vice president and chief business officer, the late-stage clinical oncology company reported Wednesday.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Sorrento Therapeutics Inc.

Company Website

6042 Cornerstone Ct. West Ste., B
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
SRNE
5.51
  0.04  
+ 0.73%
4,320,000
16.40
4.75

Sorrento Therapeutics Inc. Executive(s):

Henry Ji

  • Chief Executive Officer

Richard Vincent

  • Chief Financial Officer

Similar Companies

NAICS - 541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
SIC - 3769 - GUIDED MISSILE AND SPACE VEHICLE PARTS AND AUXILIARY EQUIPMENT, N
SIC - 3721 - AIRCRAFT
SIC - 3761 - GUIDED MISSILES AND SPACE VEHICLES
SIC - 3724 - AIRCRAFT ENGINES AND ENGINE PARTS
SIC - 3764 - GUIDED MISSILE AND SPACE VEHICLE PROPULSION UNITS AND PROPULSION
Subscribe Today!